Miller Tabak Downgrades Amgen (AMGN) to Sell; Five Reasons to Drop
Tweet Send to a Friend
Miller Tabak downgrades Amgen (Nasdaq: AMGN) from Neutral to Sell. PT $46.
Miller analyst cites the following reasons: 1) The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Miller analyst cites the following reasons: 1) The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
